Deferral of assessment of pulmonary embolism.

We evaluated a simplified algorithm for safely postponing diagnostic imaging for pulmonary embolism (PE). At the index visit, patients were identified as being at high or low risk of PE; the former received full dosage low molecular weight heparin while the latter were left untreated until performance of diagnostic imaging (max 72 hours). During this period, no thromboembolic events occurred in low-risk patients (0/211, 0.% [upper 95% CI 0.9%]); only one event occurred in those at high-risk (1/125, 0.8% [upper 95% CI, 1.2]). Our study demonstrates that diagnostic imaging for PE can be safely deferred for up to 3 days.

[1]  Pieter W Kamphuisen,et al.  Effectiveness of managing suspected pulmonary embolism using an algorithm combining clinical probability, D-dimer testing, and computed tomography. , 2006, JAMA.

[2]  P. Prandoni,et al.  The incidence of heparin-induced thrombocytopenia in medical patients treated with low-molecular-weight heparin: a prospective cohort study. , 2005, Blood.

[3]  Mel Herbert,et al.  The mortality of untreated pulmonary embolism in emergency department patients. , 2005, Annals of emergency medicine.

[4]  U. Schoepf,et al.  Spiral computed tomography is the first‐line chest imaging test for acute pulmonary embolism: yes , 2005, Journal of thrombosis and haemostasis : JTH.

[5]  G. Agnelli,et al.  Spiral computed tomography is the first‐line chest imaging test for acute pulmonary embolism: no , 2005, Journal of thrombosis and haemostasis : JTH.

[6]  C. Porta,et al.  Deferment of objective assessment of deep vein thrombosis and pulmonary embolism without increased risk of thrombosis: a practical approach based on the pretest clinical model, D-dimer testing, and the use of low-molecular-weight heparins. , 2004, Archives of internal medicine.

[7]  John Eng,et al.  Accuracy of CT in the diagnosis of pulmonary embolism: a systematic literature review. , 2004, AJR. American journal of roentgenology.

[8]  Giancarlo Agnelli,et al.  Antithrombotic therapy for venous thromboembolic disease: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. , 2004, Chest.

[9]  M. Graif,et al.  Pitfalls in the diagnosis of acute pulmonary embolism on spiral computer tomography. , 2004, Current problems in diagnostic radiology.

[10]  A. Fennerty,et al.  British Thoracic Society guidelines for the management of suspected acute pulmonary embolism , 2003, Thorax.

[11]  J. Mayo,et al.  Spiral computed tomography for acute pulmonary embolism. , 2002, Canadian Association of Radiologists journal = Journal l'Association canadienne des radiologistes.

[12]  M Gent,et al.  Use of a Clinical Model for Safe Management of Patients with Suspected Pulmonary Embolism , 1998, Annals of Internal Medicine.

[13]  W M O'Fallon,et al.  Trends in the incidence of deep vein thrombosis and pulmonary embolism: a 25-year population-based study. , 1998, Archives of internal medicine.

[14]  D. Rosenthal.  Value of the ventilation/perfusion scan in acute pulmonary embolism: The prospective investigation of pulmonary embolism diagnosis: (PIOPED) investigators. JAMA 1990; Vol. 263: 2753-9 , 1991 .

[15]  J. Bodenhamer.  Value of the ventilation/perfusion scan in acute pulmonary embolism: Saltzman HA, Alavi A, Greenspan RH, et al JAMA 263:2753–2759 May 1990 , 1990 .

[16]  P. Investigators,et al.  Value of the ventilation/perfusion scan in acute pulmonary embolism. Results of the prospective investigation of pulmonary embolism diagnosis (PIOPED). , 1990, JAMA.

[17]  R. Hull,et al.  Antithrombotic therapy for venous thromboembolic disease. , 1989 .

[18]  D. Rylatt,et al.  Rapid detection of cross-linked fibrin degradation products in plasma using monoclonal antibody-coated latex particles. , 1986, American journal of clinical pathology.

[19]  J. Hirsh,et al.  Derivation of a Simple Clinical Model to Categorize Patients Probability of Pulmonary Embolism: Increasing the Models Utility with the SimpliRED D-dimer , 2000, Thrombosis and Haemostasis.

[20]  J. Corral,et al.  The FXIII Val34Leu polymorphism in venous and arterial thromboembolism. , 2000, Haematologica.